2 active trials 0 recruiting 2 disease areas
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06843239 | Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) | Systemic Sclerosis (SSc) | Active, Not Recruiting | 2026-07-20 |
| NCT06993610 | Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | Hidradenitis Suppurativa (HS) | Active, Not Recruiting | 2026-06-30 |
Hidradenitis Suppurativa (1) · Scleroderma (1)